Hirtle Callaghan & Co’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-14,025
Closed -$392K 114
2022
Q2
$392K Sell
14,025
-9,697
-41% -$282K 0.02% 96
2022
Q1
$692K Buy
23,722
+12,703
+115% +$395K 0.03% 74
2021
Q4
$384K Buy
+11,019
New +$391K 0.02% 71

Other funds holding GNTX

Hirtle Callaghan & Co's GNTX Position: Q3 2022 in Review

Hirtle Callaghan & Co sold out of Gentex (GNTX) in Q3 2022, closing a stake of 14,025 shares — an estimated $392K sold.

Hirtle Callaghan & Co first reported a position in GNTX in Q4 2021 and held it in 3 quarters. The position peaked at $692K in Q1 2022. 455 funds tracked by Wall St. Rank hold GNTX as of Q3 2022.

  • Hirtle Callaghan & Co reported no remaining Gentex position as of Q3 2022 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 14,025 Gentex shares in Q3 2022, an estimated $392K.
  • Hirtle Callaghan & Co first reported a position in Gentex in Q4 2021 and held it in 3 quarters.
  • Hirtle Callaghan & Co's Gentex position peaked at $692K in Q1 2022.
  • 455 funds tracked by Wall St. Rank held Gentex as of Q3 2022.

Based on Hirtle Callaghan & Co's 13F filing for Q3 2022, filed 14 Nov 2022.